Molnupiravir Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 200 mg
Reference Brands:
Category: Anti Covid Medicines
Molnupiravir is a nucleoside analog that treats COVID-19 by targeting the virus. It works by disrupting the process that the virus uses to make copies of itself. This means the virus won't be able to make any more copies of itself to further spread infection. Molnupiravir is available in Tablets and strengths such as 200 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Molnupiravir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Molnupiravir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Mild-to-moderate COVID-19 in adults 18 years and older who are at high risk for severe illness
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Baricitinib
Strength:
2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View DetailsNirmatrelvir + Ritonavir
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View DetailsTocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View DetailsQuick Response Guaranteed | Verified Suppliers